Penn Vet maps PRCD progression in dogs and humans

Progressive rod-cone degeneration, or PRCD, is a well-known inherited cause of blindness in dogs and a model for some forms of human retinitis pigmentosa. Penn Vet researchers now say they’ve mapped how the disease progresses over time, identifying a consistent pattern of retinal thinning that moves from the periphery toward the center in both canine and human patients. The work builds on years of Penn-led retinal disease research showing that PRCD is a late-onset photoreceptor degeneration shared across dogs and people, and that canine OCT imaging can track outer retinal thinning as disease advances. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, a clearer map of where PRCD-related degeneration starts and how it spreads could sharpen diagnosis, staging, case monitoring, and trial design. That’s especially relevant as Penn Vet and other groups continue developing retinal clinics, imaging tools, AI-assisted diagnostics, and gene- or cell-based therapies for inherited retinal disease in dogs. Knowing that degeneration follows a reproducible peripheral-to-central pattern may help clinicians interpret OCT findings earlier and may give researchers a more precise structural endpoint for future intervention studies. (vet.upenn.edu)

What to watch: Watch for the underlying paper, fuller methods, and whether Penn’s progression map is incorporated into future PRCD screening protocols, retinal clinic workflows, or interventional studies in dogs and translational retinitis pigmentosa programs. (vet.upenn.edu)